MNK-795 is a controlled-release oral formulation of oxycodone and acetaminophen that has been studied for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.
http://eon.businesswire.com/news/eon/20130729005378/en/Mallinckrodt-Drug-Application-Granted-Priority-Review-FDA
http://eon.businesswire.com/news/eon/20130729005378/en/Mallinckrodt-Drug-Application-Granted-Priority-Review-FDA
No comments:
Post a Comment